We understand patients. And we understand industry. We bring them together.
read more …Register for free and get expert advice on Patient Engagement - new case study, new tool, new chapterread more …
Learn more about Trishnaread more …
Join our teamread more …
Including patient expertise during the entire product life-cycle is key for truly patient-focused innovative products and services. It is instrumental for successful business. However, how can this be translated into practice? That’s exactly where admedicum comes in.
What?
We help prepare your organization and shape the patient interactions in a way that creates sustainable value for both patients and your business. We provide “fit for purpose” approaches to establishing concepts, tools, advisory groups, networking, coaching and management support where it can help overcome the challenges of a complex relationship between patients and industry.
How?
We provide down-to-earth day-to-day patient-centric business solutions. Together with our clients from the industry, we make patient-industry collaboration happen. We act as advisors, designers and enablers to build trustworthy and effective relationships between patients and industry. We help to merge beneficial impact for patients and value-for-money for industry.
Testimonials
His vision of a patient centric approach to pharmaceutical development, in particular in rare and orphan diseases, together with the implementation of a concrete series of patient focused events has created a momentum that our company is still benefitting from.
During his time as CEO of Mukoviszidose e.V., the German Cystic Fibrosis (CF) Association (2002 – 2014) and Managing Director of our research affiliate, Mukoviszidose Institut GmbH (2006 – 2015), I got to appreciate Andreas Reimann. I am a father of a son living with CF and I am grateful to what Andreas has contributed to the lives of ...
Philipp possesses all the many skills needed and essential for bringing together patient organizations and their KOLs into the limelight of industry! For more than 30 years, I have promoted genetic diseases and pain awareness as a health professional with a genetic disease and chronic pain.
Rachel interacts with patients and their families with both tact and ease, ensuring that we end up with networks of people engaged and wanting to be involved. She has an ability that I think is rare to find: naturally picking up on peoples non-verbal as well as verbal meanings very quickly.
She is differentiated by her skill at delivery and bringing people together to ensure projects always deliver to time and with much good humour along the way! A true people person, she thrives in organisational situations that others might find tricky, embracing change and challenge herself and ensuring that others benefit and grow ...
Read more
Benefit to clients
We support our clients in providing patient oriented products and services. Economical and profitable products and services contribute to the added value of more patient centric health care ...
About us
admedicum team members have the credibility, expertise, skills and experience to represent both the patient and industry perspective. We have worked on the patient side and in pharma and medtech industry positions. ...
Case-studies
Learn more about our services and see some case studies in areas like „Understanding patient’s needs“, “Patient-focused products and services” and “Patient Engagement Management”.
News
admedicum recently attended the HTAi 2019 meeting in Cologne, Germany entitled, “HTA beyond 2020: Ready for the New Decade?” At admedicum, we believe patient involvement in HTA is crucial for making the right decisions because health technology is FOR THE PATIENTS. We took the opportunity of other stakeholders being in Cologne to co-host a PEGASUS Networking Event to discuss the same topic as this blog with a group of diverse stakeholders including patient-representatives from several different disease-areas.
Read more … Why involvement of patients is essential for Health Technology Assessment (HTA)
Since its release in 2018 the Patient Engagement Guide (PEG) has served subscribers from the pharmaceutical and biotech industry all over the world in their mission to incorporate Patient Engagement into their daily business.
Months have passed and admedicum has accompanied exciting projects, met inspiring people, participated in glowing discussions – all evolving around how to bring patients’ needs and industry’s’ potential closer together.
We are excited to share some of what we have learned and gather our experiences in the2.0 version of the PEG.
Read more … The Patient Engagement Guide 2.0 – new chapter, new case studies, new tools!
You are a manager in the healthcare industry or work for a statutory health insurance that develops or reimburses innovative therapy concepts? Would you like to know more about the implementation of the GSAV guidelines in practice?
Then this course is designed for you!
Read more … Forum Seminar in Berlin: Update GSAV - Financing of innovative therapies, July 3 - 2019
